XML 71 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Financial instruments
6 Months Ended
Jun. 30, 2021
Financial instruments
31 Financial instruments
The disclosure of the Group’s financial instruments below includes the following sections:
Concentration of credit risk;
Fair value measurement (including fair value hierarchy, transfers between levels; level 3 reconciliation; qualitative and quantitative disclosures of valuation techniques);
Fair value option; and
Disclosures about fair value of financial instruments not carried at fair value.
Concentrations of credit risk
Credit risk concentrations arise when a number of counterparties are engaged in similar business activities, are located in the same geographic region or when there are similar economic features that would cause their ability to meet contractual obligations to be similarly impacted by changes in economic conditions.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on the Group’s concentrations of credit risk.
Fair value measurement
A significant portion of the Group’s financial instruments is carried at fair value. Deterioration of financial markets could significantly impact the fair value of these financial instruments and the results of operations.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on fair value measurement of financial instruments and the definition of the levels of the fair value hierarchy.
Qualitative disclosures of valuation techniques
Information on the valuation techniques and significant unobservable inputs of the various financial instruments and the section “Uncertainty of fair value measurements at the reporting date from the use of significant unobservable inputs” should be read in conjunction with the tables “Assets and liabilities measured at fair value on a recurring basis”, “Quantitative information about level 3 assets measured at fair value on a recurring basis” and “Quantitative information about level 3 liabilities measured at fair value on a recurring basis”.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on the Group’s valuation techniques.
Assets and liabilities measured at fair value on a recurring basis

end of 2Q21




Level 1




Level 2




Level 3



Netting
impact
1 Assets
measured
at net
asset value
per share
2



Total
Assets (CHF million)   
Cash and due from banks 0 141 0 141
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 0 69,465 0 69,465
Securities received as collateral 33,337 5,265 84 38,686
Trading assets 63,367 161,743 5,938 (101,348) 805 130,505
   of which debt securities  11,267 44,628 1,655 70 57,620
      of which foreign governments  10,885 11,376 40 22,301
      of which corporates  265 9,854 889 70 11,078
      of which RMBS  0 20,528 477 21,005
   of which equity securities  41,037 2,172 282 735 44,226
   of which derivatives  9,422 113,199 2,883 (101,348) 24,156
      of which interest rate products  1,212 55,831 805
      of which foreign exchange products  220 19,512 139
      of which equity/index-related products  7,941 32,473 490
      of which other derivatives  0 147 1,073
   of which other trading assets  1,641 1,744 1,118 4,503
Investment securities 35 759 0 794
Other investments 13 7 2,231 496 2,747
   of which other equity investments  13 7 1,353 374 1,747
   of which life finance instruments  0 0 877 877
Loans 0 8,173 2,928 11,101
   of which commercial and industrial loans  0 1,712 1,411 3,123
   of which financial institutions  0 3,958 643 4,601
Other intangible assets (mortgage servicing rights) 0 0 189 189
Other assets 155 9,191 1,436 (440) 10,342
   of which failed purchases  126 1,590 12 1,728
   of which loans held-for-sale  0 6,433 1,287 7,720
Total assets at fair value  96,907 254,744 12,806 (101,788) 1,301 263,970
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis (continued)

end of 2Q21




Level 1




Level 2




Level 3



Netting
impact
1 Liabilities
measured
at net
asset value
per share
2



Total
Liabilities (CHF million)   
Due to banks 0 330 0 330
Customer deposits 0 3,489 432 3,921
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 0 10,983 0 10,983
Obligation to return securities received as collateral 33,337 5,265 84 38,686
Trading liabilities 24,903 113,684 3,035 (108,650) 32,972
   of which debt securities 3,230 4,823 0 8,053
      of which foreign governments 3,131 1,002 0 4,133
   of which equity securities 12,134 141 41 12,316
   of which derivatives 9,539 108,720 2,994 (108,650) 12,603
      of which interest rate products 1,184 52,087 142
      of which foreign exchange products 176 20,973 62
      of which equity/index-related products 8,127 29,144 1,738
Short-term borrowings 0 7,448 1,106 8,554
Long-term debt 0 59,763 9,673 69,436
   of which structured notes over one year and up to two years 0 11,742 2,124 13,866
   of which structured notes over two years 0 24,088 6,777 30,865
   of which high-trigger instruments 0 11,080 0 11,080
Other liabilities 90 7,557 535 (271) 7,911
Total liabilities at fair value 58,330 208,519 14,865 (108,921) 172,793
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis (continued)

end of 4Q20




Level 1




Level 2




Level 3



Netting
impact
1 Assets
measured
at net
asset value
per share
2



Total
Assets (CHF million)   
Cash and due from banks 0 525 0 525
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 0 57,994 0 57,994
Securities received as collateral 44,074 6,598 101 50,773
Trading assets 87,710 181,166 7,535 (119,731) 658 157,338
   of which debt securities  16,321 45,766 2,253 55 64,395
      of which foreign governments  15,908 11,909 140 27,957
      of which corporates  353 9,799 1,270 55 11,477
      of which RMBS  0 20,882 557 21,439
   of which equity securities  60,044 2,466 124 603 63,237
   of which derivatives  9,297 132,054 3,911 (119,731) 25,531
      of which interest rate products  3,036 71,043 733
      of which foreign exchange products  42 24,259 143
      of which equity/index-related products  6,150 31,945 1,186
      of which other derivatives  22 110 1,079
   of which other trading assets  2,048 880 1,247 4,175
Investment securities 2 605 0 607
Other investments 13 6 3,054 721 3,794
   of which other equity investments  13 6 2,132 608 2,759
   of which life finance instruments  0 0 920 920
Loans 0 7,739 3,669 11,408
   of which commercial and industrial loans  0 2,187 1,347 3,534
   of which financial institutions  0 3,506 1,082 4,588
Other intangible assets (mortgage servicing rights) 0 0 180 180
Other assets 137 7,315 1,825 (904) 8,373
   of which failed purchases  109 1,229 51 1,389
   of which loans held-for-sale  0 4,870 1,576 6,446
Total assets at fair value  131,936 261,948 16,364 (120,635) 1,379 290,992
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis (continued)

end of 4Q20




Level 1




Level 2




Level 3



Netting
impact
1 Liabilities
measured
at net
asset value
per share
2



Total
Liabilities (CHF million)   
Due to banks 0 413 0 413
Customer deposits 0 3,895 448 4,343
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 0 13,594 0 13,594
Obligation to return securities received as collateral 44,074 6,598 101 50,773
Trading liabilities 33,544 137,947 4,246 (129,867) 1 45,871
   of which equity securities 20,527 111 55 1 20,694
   of which derivatives 10,536 132,885 4,191 (129,867) 17,745
      of which interest rate products  3,264 68,159 169
      of which foreign exchange products  51 28,819 72
      of which equity/index-related products  7,149 30,612 2,010
      of which credit derivatives 0 4,663 1,335
Short-term borrowings 0 10,039 701 10,740
Long-term debt 0 63,708 7,268 70,976
   of which structured notes over one year and up to two years 0 11,787 1,133 12,920
   of which structured notes over two years 0 28,330 5,526 33,856
   of which high-trigger instruments 0 10,586 0 10,586
Other liabilities 0 6,678 1,271 (169) 7,780
Total liabilities at fair value 77,618 242,872 14,035 (130,036) 1 204,490
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis for level 3
   
Trading revenues

Other revenues
Accumulated other
comprehensive income

6M21

Balance at
beginning
of period


Transfers
in


Transfers
out



Purchases



Sales



Issuances



Settlements

On
transfers
out


On all
other

On
transfers
out


On all
other

On
transfers
out


On all
other
Foreign
currency
translation
impact

Balance
at end
of period

Changes in
unrealized
gains/losses
1
Assets (CHF million)   
Securities received as collateral 101 0 0 64 (86) 0 0 0 0 0 0 0 0 5 84 0
Trading assets 7,535 594 (1,635) 2,472 (2,976) 508 (1,119) 39 140 0 0 0 0 380 5,938 128
   of which debt securities  2,253 296 (736) 1,859 (2,285) 0 0 (7) 138 0 0 0 0 137 1,655 103
      of which corporates  1,270 137 (176) 1,403 (1,913) 0 0 (5) 95 0 0 0 0 78 889 99
   of which derivatives  3,911 179 (856) 0 0 508 (1,033) 29 (30) 0 0 0 0 175 2,883 72
      of which interest rate products  733 59 (81) 0 0 114 (59) 0 18 0 0 0 0 21 805 54
      of which other derivatives  1,079 0 0 0 0 153 (157) 0 (55) 0 0 0 0 53 1,073 (60)
   of which other trading assets  1,247 22 (32) 493 (617) 0 (86) 10 21 0 0 0 0 60 1,118 (47)
Other investments 3,054 3 (753) 20 (473) 0 0 0 (17) 0 318 0 0 79 2,231 43
   of which other equity investments  2,132 0 (753) 3 (375) 0 0 0 (6) 0 318 0 0 34 1,353 52
   of which life finance instruments  920 0 0 17 (94) 0 0 0 (11) 0 0 0 0 45 877 18
Loans 3,669 22 (533) 357 (73) 162 (946) 8 85 0 1 0 0 176 2,928 25
   of which commercial and industrial loans  1,347 22 (12) 10 (31) 119 (184) 14 57 0 1 0 0 68 1,411 36
   of which financial institutions  1,082 0 (222) 0 (42) 32 (296) 3 40 0 0 0 0 46 643 4
Other intangible assets (mortgage servicing rights) 180 0 0 22 0 0 0 0 0 0 (22) 0 0 9 189 (22)
Other assets 1,825 164 (451) 2,500 (2,176) 77 (573) 13 (42) 0 0 0 0 99 1,436 (76)
   of which loans held-for-sale  1,576 164 (409) 2,469 (2,137) 77 (571) 11 19 0 0 0 0 88 1,287 (41)
Total assets at fair value  16,364 783 (3,372) 5,435 (5,784) 747 (2,638) 60 166 0 297 0 0 748 12,806 98
Liabilities (CHF million)   
Customer deposits 448 0 0 0 0 0 0 0 (8) 0 0 0 (13) 5 432 10
Obligation to return securities received as collateral 101 0 0 64 (86) 0 0 0 0 0 0 0 0 5 84 0
Trading liabilities 4,246 584 (1,961) 80 (24) 710 (1,138) 152 169 0 0 0 0 217 3,035 779
   of which derivatives  4,191 566 (1,961) 69 (4) 710 (1,138) 152 193 0 0 0 0 216 2,994 781
      of which equity/index-related derivatives  2,010 427 (1,049) 0 0 350 (527) 151 265 0 0 0 0 111 1,738 529
Short-term borrowings 701 155 (207) 0 0 930 (608) (1) 95 0 0 0 0 41 1,106 67
Long-term debt 7,268 2,715 (2,046) 0 0 4,401 (3,119) 62 (4) 0 4 (3) (30) 425 9,673 210
   of which structured notes over one year and up to two years  1,133 1,165 (732) 0 0 1,127 (771) 39 97 0 0 0 (1) 67 2,124 39
   of which structured notes over two years  5,526 1,532 (1,287) 0 0 3,020 (2,227) 24 (109) 0 0 (2) (29) 329 6,777 (59)
Other liabilities 1,271 7 (552) 24 (46) 59 (424) 8 (8) 107 38 0 0 51 535 2
Total liabilities at fair value  14,035 3,461 (4,766) 168 (156) 6,100 (5,289) 221 244 107 42 (3) (43) 744 14,865 1,068
Net assets/(liabilities) at fair value  2,329 (2,678) 1,394 5,267 (5,628) (5,353) 2,651 (161) (78) (107) 255 3 43 4 (2,059) (970)
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in unrealized (gains)/losses on total liabilities at fair value relating to assets and liabilities held at period end are included in net revenues or accumulated other comprehensive income. As of 6M21, changes in net unrealized gains/(losses) of CHF (1,011) million and CHF 25 million were recorded in trading revenues and other revenues, respectively, and changes in unrealized (gains)/losses of CHF 16 million were recorded in Gains/(losses) on liabilities relating to credit risk in Accumulated other comprehensive income/(loss).
 
Assets and liabilities measured at fair value on a recurring basis for level 3 (continued)
   
Trading revenues

Other revenues
Accumulated other
comprehensive income

6M20

Balance at
beginning
of period


Transfers
in


Transfers
out



Purchases



Sales



Issuances



Settlements

On
transfers
out


On all
other

On
transfers
out


On all
other

On
transfers
out


On all
other
Foreign
currency
translation
impact

Balance
at end
of period

Changes in
unrealized
gains/losses
1
Assets (CHF million)   
Securities received as collateral 1 0 0 173 (1) 0 0 0 0 0 0 0 0 (3) 170 0
Trading assets 7,885 2,489 (1,502) 4,272 (4,657) 1,290 (1,625) 169 796 (1) 0 0 0 (319) 8,797 1,076
   of which debt securities  1,923 1,654 (708) 2,527 (2,000) 0 0 59 (122) 0 0 0 0 (135) 3,198 (19)
      of which corporates  1,128 559 (564) 1,718 (1,230) 0 0 67 42 0 0 0 0 (78) 1,642 96
      of which RMBS  317 902 (70) 557 (525) 0 0 (4) (70) 0 0 0 0 (5) 1,102 (55)
   of which derivatives  3,534 719 (629) 0 0 1,290 (1,606) 111 834 (1) 0 0 0 (151) 4,101 999
      of which equity/index-related products  1,040 220 (240) 0 0 345 (597) 35 345 0 0 0 0 (81) 1,067 361
      of which credit derivatives  879 379 (305) 0 0 700 (771) 100 211 0 0 0 0 (21) 1,172 325
      of which other derivatives  909 0 0 0 0 155 (165) 0 207 0 0 0 0 (21) 1,085 210
   of which other trading assets  2,231 100 (144) 1,707 (2,639) 0 (19) (1) 151 0 0 0 0 (30) 1,356 11
Other investments 2,523 2 0 371 (107) 0 0 0 95 0 (19) 0 0 (26) 2,839 38
   of which other equity investments  1,463 1 0 354 (19) 0 0 0 (11) 0 (18) 0 0 (5) 1,765 (35)
   of which life finance instruments  1,052 0 0 17 (88) 0 0 0 106 0 0 0 0 (21) 1,066 74
Loans 2 3,835 641 (375) 90 (479) 742 (569) 38 (336) 0 0 0 0 (74) 3,513 (296)
   of which commercial and industrial loans 2 1,401 390 (137) 45 (282) 447 (173) 3 (194) 0 0 0 0 (27) 1,473 (205)
   of which financial institutions  1,201 44 (94) 0 (32) 275 (211) 13 (70) 0 0 0 0 (26) 1,100 (77)
Other intangible assets (mortgage servicing rights) 244 0 0 0 0 0 0 0 0 0 (31) 0 0 (4) 209 (31)
Other assets 1,846 1,432 (383) 2,400 (2,260) 282 (543) 16 (60) 0 0 0 0 (149) 2,581 (6)
   of which loans held-for-sale  1,619 1,409 (339) 2,373 (2,259) 282 (543) (8) (87) 0 0 0 0 (143) 2,304 (87)
Total assets at fair value  16,334 4,564 (2,260) 7,306 (7,504) 2,314 (2,737) 223 495 (1) (50) 0 0 (575) 18,109 781
Liabilities (CHF million)   
Customer deposits 474 0 0 0 0 0 (27) 0 35 0 0 0 (22) (27) 433 9
Obligation to return securities received as collateral 1 0 0 173 (1) 0 0 0 0 0 0 0 0 (3) 170 0
Trading liabilities 3,854 513 (904) 210 (195) 1,602 (1,276) 184 (151) (5) 0 0 0 (105) 3,727 577
   of which derivatives  3,801 497 (904) 0 (3) 1,602 (1,276) 184 (136) (5) 0 0 0 (103) 3,657 575
      of which equity/index-related derivatives  1,921 126 (493) 0 0 585 (486) 69 (262) 0 0 0 0 (59) 1,401 274
      of which credit derivatives  1,211 333 (373) 0 0 896 (574) 117 (21) 0 0 0 0 (31) 1,558 135
Short-term borrowings 997 52 (200) 0 0 470 (706) (2) (118) 0 0 0 0 (13) 480 (40)
Long-term debt 12,610 1,843 (5,514) 0 0 4,294 (3,614) 461 (1,241) 0 0 87 (166) (269) 8,491 (110)
   of which structured notes over one year and up to two years  891 186 (423) 0 0 632 (435) 28 (111) 0 0 1 5 (18) 756 (30)
   of which structured notes over two years  11,458 707 (5,077) 0 0 3,631 (3,140) 433 (1,138) 0 0 87 (170) (245) 6,546 (89)
Other liabilities 1,385 168 (112) 195 (227) 64 (289) (27) (15) 0 86 0 0 (27) 1,201 43
Total liabilities at fair value  19,321 2,576 (6,730) 578 (423) 6,430 (5,912) 616 (1,490) (5) 86 87 (188) (444) 14,502 479
Net assets/(liabilities) at fair value  (2,987) 1,988 4,470 6,728 (7,081) (4,116) 3,175 (393) 1,985 4 (136) (87) 188 (131) 3,607 302
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in unrealized (gains)/losses on total liabilities at fair value relating to assets and liabilities held at period end are included in net revenues or accumulated other comprehensive income. As of 6M20, changes in net unrealized gains/(losses) of CHF 289 million and CHF (36) million were recorded in trading revenues and other revenues, respectively, and changes in unrealized (gains)/losses of CHF 49 million were recorded in Gains/(losses) on liabilities relating to credit risk in Accumulated other comprehensive income/(loss).
2
Includes an adjustment of CHF 118 million reflecting the impact of applying the fair value option on certain loans (previously held at amortized cost) at the adoption of the ASU 2019-05.
 
Both observable and unobservable inputs may be used to determine the fair value of positions that have been classified within level 3. As a result, the unrealized gains and losses for assets and liabilities within level 3 presented in the table above may include changes in fair value that were attributable to both observable and unobservable inputs.
The Group employs various economic hedging techniques in order to manage risks, including risks in level 3 positions. Such techniques may include the purchase or sale of financial instruments that are classified in levels 1 and/or 2. The realized and unrealized gains and losses for assets and liabilities in level 3 presented in the table above do not reflect the related realized or unrealized gains and losses arising on economic hedging instruments classified in levels 1 and/or 2.
The Group typically uses nonfinancial assets measured at fair value on a recurring or nonrecurring basis in a manner that reflects their highest and best use.
Transfers in and out of level 3
Transfers into level 3 assets during 6M21 were CHF 783 million, primarily from trading assets. These transfers were primarily in the credit and securitized products businesses, due to limited observability of pricing data and reduced pricing information from external providers. Transfers out of level 3 assets during 6M21 were CHF 3,372 million, primarily in trading assets, other investments and loans. These transfers were mainly related to global trading solutions and securitized products businesses, due to improved observability of pricing data and increased availability of pricing information from external providers, and the Group’s equity investment in Allfunds Group, following its IPO.
Transfers into level 3 assets during 2Q21 were CHF 385 million, primarily from trading assets. These transfers were primarily in the credit and securitized products businesses, due to limited observability of pricing data and reduced pricing information from external providers. Transfers out of level 3 assets during 2Q21 were CHF 1,611 million, primarily in other investments and trading assets. These transfers were mainly related to the securitized products business, due to improved observability of pricing data and increased availability of pricing information from external providers, and the Group’s equity investment in Allfunds Group, following its IPO.
Uncertainty of fair value measurements at the reporting date from the use of significant unobservable inputs
For level 3 assets with significant unobservable inputs of buyback probability, contingent probability, correlation, dividend yield, funding spread, mean reversion, mortality rate, price, recovery rate, volatility or unadjusted NAV, in general, an increase in the significant unobservable input would increase the fair value. For level 3 assets with significant unobservable inputs of credit spread, default rate, discount rate, fund gap risk, gap risk, market implied life expectancy (for life settlement and premium finance instruments), prepayment rate or tax swap rate, in general, an increase in the significant unobservable input would decrease the fair value.
For level 3 liabilities, in general, an increase in the related significant unobservable inputs would have an inverse impact on fair value. An increase in the significant unobservable inputs contingent probability, credit spread, fund gap risk, gap risk, market implied life expectancy, mortality rate or price would increase the fair value. An increase in the significant unobservable inputs of buyback probability, correlation, discount rate, dividend yield, funding spread, mean reversion, prepayment rate, unadjusted NAV or volatility would decrease the fair value.
Interrelationships between significant unobservable inputs
Except as noted above, there are no material interrelationships between the significant unobservable inputs for the financial instruments. As the significant unobservable inputs move independently, generally an increase or decrease in one significant unobservable input will have no impact on the other significant unobservable inputs.
Quantitative disclosures of valuation techniques
The following tables provide the representative range of minimum and maximum values and the associated weighted averages of each significant unobservable input for level 3 assets and liabilities by the related valuation technique most significant to the related financial instrument.
Quantitative information about level 3 assets measured at fair value on a recurring basis

end of 2Q21

Fair value
Valuation
technique
Unobservable
input
Minimum
value
Maximum
value
Weighted
average
1
CHF million, except where indicated
Trading assets 5,938
   of which debt securities  1,655
      of which corporates  889
         of which  172 Discounted cash flow Credit spread, in bp 40 973 1,928
  Price, in % 0 100 28
  Recovery rate, in % 1 1 0
         of which  12 Market comparable Price, in % 0 100 63
         of which  641 Option model Buyback probability, in % 50 100 73
  Correlation, in % (85) 100 68
  Credit spread, in bp (4) 105 81
  Fund gap risk, in % 2 0 3 1
  Volatility, in % 0 137 18
         of which  5 Vendor price Price, in actuals 0 153 135
         of which  55 Price Price, in % 32 116 86
   of which derivatives  2,883
      of which interest rate products  805
         of which  7 Discounted cash flow Prepayment rate, in % 3 10 6
  Volatility, in % 93 97 95
         of which  756 Option model Correlation, in % 1 100 8
  Mean reversion, in % 2 (55) (8) 0
  Prepayment rate, in % 3 28 10
  Volatility, in % (3) 1 0
      of which other derivatives  1,073 Discounted cash flow Market implied life expectancy, in years 2 15 6
  Mortality rate, in % 72 137 98
   of which other trading assets  1,118
         of which  728 Discounted cash flow Market implied life expectancy, in years 3 14 7
  Tax swap rate, in % 30 30 30
      of which  256 Market comparable Price, in % 0 125 28
         of which  133 Option model Mortality rate, in % 0 70 6
Other investments 2,231
   of which other equity investments  1,353
      of which  974 Adjusted NAV Price, in actuals 310 310 310
      of which  326 Price Price, in % 100 100 100
  Price, in actuals 1 1,244 425
   of which life finance instruments  877 Discounted cash flow Market implied life expectancy, in years 2 16 6
Loans 2,928
   of which commercial and industrial loans  1,411
      of which  724 Discounted cash flow Credit spread, in bp 146 2,014 589
      of which  597 Price Credit spread, in bp 300 300 300
  Price, in % 7 100 77
   of which financial institutions  643
      of which  529 Discounted cash flow Credit spread, in bp 164 1,615 622
      of which  113 Price Price, in % 10 61 28
Other assets 1,436
   of which loans held-for-sale  1,287
      of which  354 Discounted cash flow Credit spread, in bp 279 932 325
      of which  885 Market comparable Price, in % 0 152 81
      of which  17 Price Price, in % 0 63 53
1
Weighted average is calculated based on the fair value of the instruments.
2
Risk of unexpected large declines in the underlying values occurring between collateral settlement dates.
Quantitative information about level 3 assets measured at fair value on a recurring basis (continued)

end of 4Q20

Fair value
Valuation
technique
Unobservable
input
Minimum
value
Maximum
value
Weighted
average
1
CHF million, except where indicated
Trading assets 7,535
   of which debt securities  2,253
      of which corporates  1,270
         of which  386 Discounted cash flow Credit spread, in bp (9) 1,509 1,007
         of which  321 Market comparable Price, in % 0 227 95
         of which  416 Option model Correlation, in % (50) 100 55
  Gap risk, in % 2 0 2 0
  Recovery rate, in % 40 40 40
  Volatility, in % 0 158 23
         of which  71 Vendor price Price, in actuals 0 2,292 1,654
  Unadjusted NAV, in actuals 1 1 1
   of which derivatives  3,911
      of which equity/index-related products  1,186 Option model Buyback probability, in % 50 100 66
  Correlation, in % (50) 100 58
  Gap risk, in % 2 0 4 0
  Volatility, in % (2) 158 24
      of which other derivatives  1,079 Discounted cash flow Market implied life expectancy, in years 2 14 6
  Mortality rate, in % 72 137 98
   of which other trading assets  1,247
      of which  766 Discounted cash flow Market implied life expectancy, in years 3 14 7
Other investments 3,054
   of which other equity investments  2,132
      of which  840 Discounted cash flow Discount rate, in % 9 9 9
  Terminal growth rate, in % 3 3 3
      of which  118 Market comparable Price, in % 100 100 100
      of which  974 Adjusted NAV Price, in actuals 310 310 310
      of which  110 Vendor price Price, in actuals 1 1,249 713
   of which life finance instruments  920 Discounted cash flow Market implied life expectancy, in years 2 15 6
Loans 3,669
   of which commercial and industrial loans  1,347
      of which  908 Discounted cash flow Credit spread, in bp 237 1,480 554
  Recovery rate, in % 25 25 25
      of which  338 Market comparable Price, in % 0 100 70
  72 Option model Pre-IPO intrinsic option, in actuals 100 100 100
   of which financial institutions  1,082
      of which  674 Discounted cash flow Credit spread, in bp 192 1,698 612
  Recovery rate, in % 25 40 25
      of which  190 Market comparable Price, in % 0 100 54
Other assets 1,825
   of which loans held-for-sale  1,576
      of which  296 Discounted cash flow Credit spread, in bp 246 506 343
  Recovery rate, in % 1 40 34
      of which  1,277 Market comparable Price, in % 0 111 71
1
Weighted average is calculated based on the fair value of the instruments.
2
Risk of unexpected large declines in the underlying values occurring between collateral settlement dates.
Quantitative information about level 3 liabilities measured at fair value on a recurring basis

end of 2Q21

Fair value
Valuation
technique
Unobservable
input
Minimum
value
Maximum
value
Weighted
average
1
CHF million, except where indicated   
Trading liabilities 3,035
   of which derivatives  2,994
      of which equity/index-related derivatives  1,738
         of which  3 Market comparable Price, in actuals 0 34 30
         of which  1,688 Option model Buyback probability, in % 2 50 100 73
  Correlation, in % (85) 100 67
  Dividend yield, in % 1 8 4
  Unadjusted NAV, in actuals 42 3,544 876
  Volatility, in % (3) 137 18
         of which  46 Price Price, in actuals 0 1,636 1
Short-term borrowings 1,106
   of which  44 Discounted cash flow Credit spread, in bp 104 1,036 788
   of which  968 Option model Buyback probability, in % 2 50 100 73
  Correlation, in % (85) 100 68
  Fund gap risk, in % 3 0 3 1
  Gap risk, in % 3 0 4 1
  Volatility, in % 0 137 16
   of which  12 Price Price, in % 59 59 59
Long-term debt 9,673
   of which structured notes over one year and    up to two years  2,124
      of which  12 Discounted cash flow Credit spread, in bp 40 40 40
      of which  2,110 Option model Buyback probability, in % 2 50 100 73
  Correlation, in % (85) 100 69
  Credit spread, in bp (4) 105 81
  Fund gap risk, in % 3 0 3 1
  Gap risk, in % 3 0 4 1
  Unadjusted NAV, in actuals 42 3,544 876
  Volatility, in % 0 137 18
   of which structured notes over two years  6,777
      of which  110 Discounted cash flow Credit spread, in bp 2 309 84
      of which  6,521 Option model Buyback probability, in % 2 50 100 73
  Correlation, in % (85) 100 68
  Credit spread, in bp (4) 105 81
  Fund gap risk, in % 3 0 3 1
  Unadjusted NAV, in actuals 42 3,544 876
  Volatility, in % 0 137 14
      of which  12 Price Price, in % 4 26 21
1
Weighted average is calculated based on the fair value of the instruments.
2
Estimate of probability of structured notes being put back to the Group at the option of the investor over the remaining life of the financial instruments.
3
Risk of unexpected large declines in the underlying values occurring between collateral settlement dates.
Quantitative information about level 3 liabilities measured at fair value on a recurring basis (continued)

end of 4Q20

Fair value
Valuation
technique
Unobservable
input
Minimum
value
Maximum
value
Weighted
average
1
CHF million, except where indicated   
Trading liabilities 4,246
   of which derivatives  4,191
      of which equity/index-related derivatives  2,010 Option model Buyback probability, in % 2 50 100 66
  Correlation, in % (50) 100 58
  Volatility, in % (2) 158 27
      of which credit derivatives  1,335
         of which  738 Discounted cash flow Correlation, in % 37 45 44
  Credit spread, in bp 0 1,468 391
  Default rate, in % 0 7 3
  Discount rate, in % 6 19 14
  Funding spread, in bp 55 183 120
  Loss severity, in % 0 100 68
  Prepayment rate, in % 0 9 7
  Recovery rate, in % 12 81 38
         of which  520 Market comparable Price, in % 84 116 99
         of which  12 Option model Correlation, in % 49 50 50
  Credit spread, in bp 13 865 250
Short-term borrowings 701
   of which  58 Discounted cash flow Credit spread, in bp (4) 992 722
  Recovery rate, in % 35 40 39
   of which  508 Option model Buyback probability, in % 50 100 66
  Correlation, in % (50) 100 56
  Fund gap risk, in % 3 0 2 0
  Volatility, in % 3 158 30
Long-term debt 7,268
   of which structured notes over one year and    up to two years  1,133
      of which  48 Discounted cash flow Credit spread, in bp 35 189 52
  Recovery rate, in % 25 25 25
      of which  1,051 Option model Buyback probability, in % 2 50 100 66
  Correlation, in % (50) 100 55
  Fund gap risk, in % 3 0 2 0
  Gap risk, in % 0 4 1
  Volatility, in % 0 158 24
   of which structured notes over two years  5,526
      of which  1,380 Discounted cash flow Credit spread, in bp (14) 481 58
  Recovery rate, in % 23 40 38
      of which  9 Market comparable Price, in % 27 46 27
      of which  3,961 Option model Buyback probability, in % 2 50 100 66
  Correlation, in % (50) 100 55
  Gap risk, in % 3 0 2 0
  Mean reversion, in % 4 (10) 0 (5)
  Volatility, in % 0 158 21
1
Weighted average is calculated based on the fair value of the instruments.
2
Estimate of probability of structured notes being put back to the Group at the option of the investor over the remaining life of the financial instruments.
3
Risk of unexpected large declines in the underlying values occurring between collateral settlement dates.
4
Management's best estimate of the speed at which interest rates will revert to the long-term average.
Qualitative discussion of the ranges of significant unobservable inputs
The level of aggregation and diversity within the financial instruments disclosed in the tables above results in certain ranges of significant inputs being wide and unevenly distributed across asset and liability categories.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on the Group’s qualitative discussion of the ranges of signification unobservable inputs.
Investment funds measured at net asset value per share
Certain investment funds are measured at net asset value per share.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on investment funds measured at net asset value per share.
Assets and liabilities measured at fair value on a nonrecurring basis
Certain assets and liabilities are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on assets and liabilities measured at fair value on a nonrecurring basis.
Fair value option
The Group has availed itself of the simplification in accounting offered under the fair value option. This has been accomplished generally by electing the fair value option, both at initial adoption and for subsequent transactions, on items impacted by the hedge accounting requirements of US GAAP. For instruments for which hedge accounting could not be achieved but for which the Group is economically hedged, the Group has generally elected the fair value option. Where the Group manages an activity on a fair value basis but previously has been unable to achieve fair value accounting, the Group has generally utilized the fair value option to align its financial accounting to its risk management reporting.
> Refer to “Note 36 – Financial instruments” in VI – Consolidated financial statements – Credit Suisse Group in the Credit Suisse Annual Report 2020 for further information on the Group’s election of the fair value option.
Difference between the aggregate fair value and unpaid principal balances of fair value option-elected financial instruments
   2Q21 4Q20

end of
Aggregate
fair
value
Aggregate
unpaid
principal


Difference
Aggregate
fair
value
Aggregate
unpaid
principal


Difference
Financial instruments (CHF million)   
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 69,465 69,314 151 57,994 57,895 99
Loans 11,101 11,804 (703) 11,408 12,079 (671)
Other assets 1 9,448 12,122 (2,674) 7,834 10,090 (2,256)
Due to banks and customer deposits (538) (471) (67) (578) (489) (89)
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions (10,983) (10,982) (1) (13,594) (13,578) (16)
Short-term borrowings (8,554) (8,556) 2 (10,740) (10,632) (108)
Long-term debt 2 (69,436) (71,204) 1,768 (70,976) (73,842) 2,866
Other liabilities (883) (1,844) 961 (616) (1,569) 953
Non-performing and non-interest-earning loans 3 591 3,543 (2,952) 543 3,364 (2,821)
1
Primarily loans held-for-sale.
2
Long-term debt includes both principal-protected and non-principal protected instruments. For non-principal-protected instruments, the original notional amount has been reported in the aggregate unpaid principal.
3
Included in loans or other assets.
Gains and losses on financial instruments
   6M21 6M20

in
Net
gains/
(losses)
Net
gains/
(losses)
Financial instruments (CHF million)   
Interest-bearing deposits with banks 18 1 1 1
   of which related to credit risk  8 (6)
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 306 1 789 1
Other investments 293 2 205 3
   of which related to credit risk  0 1
Loans 277 1 (247) 3
   of which related to credit risk  59 (575)
Other assets 405 1 416 1
   of which related to credit risk  173 (19)
Due to banks and customer deposits (37) 3 (39) 3
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions (29) 1 (82) 1
Short-term borrowings (406) 3 (16) 3
   of which related to credit risk  (1) 1
Long-term debt (3,802) 3 1,270 3
   of which related to credit risk  0 14
Other liabilities 120 2 (102) 3
   of which related to credit risk  67 (124)
1
Primarily recognized in net interest income.
2
Primarily recognized in other revenues.
3
Primarily recognized in trading revenues.
Gains and losses attributable to changes in instrument-specific credit risk on fair value option elected liabilities
The following table provides additional information regarding the gains and losses attributable to changes in instrument-specific credit risk on fair value option elected liabilities, which have been recorded in AOCI. The table includes both the amount of change during the period and the cumulative amount that were attributable to the changes in instrument-specific credit risk. In addition, the table includes the gains and losses related to instrument-specific credit risk, which were previously recorded in AOCI but have been transferred to net income during the period.
Gains/(losses) attributable to changes in instrument-specific credit risk
    

Gains/(losses) recorded into AOCI
1 Gains/(losses) recorded
in AOCI transferred
to net income
1
in 2Q21 Cumulative 2Q20 2Q21 2Q20
Financial instruments (CHF million)   
Customer deposits (1) (64) (15) 0 0
Short-term borrowings 3 (55) (24) 0 0
Long-term debt (518) (2,464) (3,150) 31 22
   of which treasury debt over two years  (523) (1,121) (1,632) 0 0
   of which structured notes over two years  (9) (1,252) (1,253) 31 22
Total  (516) (2,583) (3,189) 31 22
1
Amounts are reflected gross of tax.
Financial instruments not carried at fair value
The following table provides the carrying value and fair value of financial instruments which are not carried at fair value in the consolidated balance sheet. The disclosure excludes all non-financial instruments, such as lease transactions, real estate, premises and equipment, equity method investments and pension and benefit obligations.
Carrying value and fair value of financial instruments not carried at fair value
    Carrying
value

Fair value
end of Level 1 Level 2 Level 3 Total
2Q21 (CHF million)
Financial assets 
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 25,179 0 25,180 0 25,180
Loans 285,192 0 280,554 13,252 293,806
Other financial assets 1 161,682 145,446 16,030 288 161,764
Financial liabilities 
Due to banks and customer deposits 413,995 239,202 174,860 0 414,062
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 9,941 0 9,941 0 9,941
Short-term borrowings 13,813 0 13,813 0 13,813
Long-term debt 100,790 0 100,867 2,968 103,835
Other financial liabilities 2 14,389 0 13,950 406 14,356
4Q20 (CHF million)
Financial assets 
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 21,139 0 21,139 0 21,139
Loans 277,137 0 272,660 14,534 287,194
Other financial assets 1 155,266 138,672 16,315 303 155,290
Financial liabilities 
Due to banks and customer deposits 402,589 234,700 167,924 0 402,624
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 10,256 0 10,256 0 10,256
Short-term borrowings 10,128 0 10,128 0 10,128
Long-term debt 90,111 0 90,897 2,317 93,214
Other financial liabilities 2 16,012 0 15,567 412 15,979
1
Primarily includes cash and due from banks, interest-bearing deposits with banks, loans held-for-sale, cash collateral on derivative instruments, interest and fee receivables and non-marketable equity securities.
2
Primarily includes cash collateral on derivative instruments and interest and fee payables.
Bank  
Financial instruments
30 Financial instruments
> Refer to “Note 31 – Financial instruments” in III – Condensed consolidated financial statements – unaudited in the Credit Suisse Financial Report 2Q21 and to “Note 35 – Financial instruments” in VIII – Consolidated financial statements – Credit Suisse (Bank) in the Credit Suisse Annual Report 2020 for further information.
Assets and liabilities measured at fair value on a recurring basis

end of 6M21




Level 1




Level 2




Level 3



Netting
impact
1 Assets
measured
at net
asset value
per share
2



Total
Assets (CHF million)   
Cash and due from banks 0 141 0 141
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 0 69,465 0 69,465
Securities received as collateral 33,337 5,265 84 38,686
Trading assets 63,427 161,961 5,938 (101,447) 805 130,684
   of which debt securities  11,267 44,747 1,655 70 57,739
      of which foreign government  10,885 11,376 40 22,301
      of which corporates  265 9,973 889 70 11,197
      of which RMBS  0 20,528 477 21,005
   of which equity securities  41,098 2,172 282 735 44,287
   of which derivatives  9,422 113,297 2,883 (101,447) 24,155
      of which interest rate products  1,212 55,930 805
      of which foreign exchange products  220 19,512 139
      of which equity/index-related products  7,941 32,473 490
      of which other derivatives  0 146 1,073
   of which other trading assets  1,640 1,745 1,118 4,503
Investment securities 33 759 0 792
Other investments 13 7 2,231 495 2,746
   of which other equity investments  13 7 1,353 373 1,746
   of which life finance instruments  0 0 877 877
Loans 0 8,173 2,928 11,101
   of which commercial and industrial loans  0 1,712 1,411 3,123
   of which financial institutions  0 3,958 643 4,601
Other intangible assets (mortgage servicing rights) 0 0 189 189
Other assets 155 9,191 1,436 (440) 10,342
   of which failed purchases  126 1,590 12 1,728
   of which loans held-for-sale  0 6,433 1,287 7,720
Total assets at fair value  96,965 254,962 12,806 (101,887) 1,300 264,146
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis (continued)

end of 6M21




Level 1




Level 2




Level 3



Netting
impact
1 Liabilities
measured
at net
asset value
per share
2



Total
Liabilities (CHF million)   
Due to banks 0 330 0 330
Customer deposits 0 3,489 432 3,921
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 0 11,080 0 11,080
Obligation to return securities received as collateral 33,337 5,265 84 38,686
Trading liabilities 24,903 113,741 3,035 (108,708) 32,971
   of which debt securities  3,230 4,824 0 8,054
      of which foreign government  3,131 1,002 0 4,133
   of which equity securities  12,133 141 41 12,315
   of which derivatives  9,540 108,776 2,994 (108,708) 12,602
      of which interest rate products  1,184 52,145 142
      of which foreign exchange products  176 20,973 62
      of which equity/index-related products  8,127 29,143 1,738
Short-term borrowings 0 7,448 1,106 8,554
Long-term debt 0 58,813 9,673 68,486
   of which structured notes over one year and up to two years  0 11,742 2,124 13,866
   of which structured notes over two years  0 24,088 6,777 30,865
   of which high-trigger instruments  0 11,124 0 11,124
Other liabilities 90 7,537 535 (271) 7,891
Total liabilities at fair value  58,330 207,703 14,865 (108,979) 171,919
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis (continued)

end of 2020




Level 1




Level 2




Level 3



Netting
impact
1 Assets
measured
at net
asset value
per share
2



Total
Assets (CHF million)   
Cash and due from banks 0 525 0 525
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 0 57,994 0 57,994
Securities received as collateral 44,074 6,598 101 50,773
Trading assets 87,746 181,303 7,535 (119,731) 658 157,511
   of which debt securities  16,321 45,903 2,253 55 64,532
      of which foreign government  15,908 11,909 140 27,957
      of which corporates  353 9,936 1,270 55 11,614
      of which RMBS  0 20,882 557 21,439
   of which equity securities  60,080 2,466 124 603 63,273
   of which derivatives  9,297 132,054 3,911 (119,731) 25,531
      of which interest rate products  3,036 71,043 733
      of which foreign exchange products  42 24,259 143
      of which equity/index-related products  6,150 31,945 1,186
      of which other derivatives  22 110 1,079
   of which other trading assets  2,048 880 1,247 4,175
Investment securities 1 604 0 605
Other investments 13 6 3,054 720 3,793
   of which other equity investments  13 6 2,132 609 2,760
   of which life finance instruments  0 0 920 920
Loans 0 7,739 3,669 11,408
   of which commercial and industrial loans  0 2,187 1,347 3,534
   of which financial institutions  0 3,506 1,082 4,588
Other intangible assets (mortgage servicing rights) 0 0 180 180
Other assets 137 7,315 1,825 (904) 8,373
   of which failed purchases  109 1,229 51 1,389
   of which loans held-for-sale  0 4,870 1,576 6,446
Total assets at fair value  131,971 262,084 16,364 (120,635) 1,378 291,162
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis (continued)

end of 2020




Level 1




Level 2




Level 3



Netting
impact
1 Liabilities
measured
at net
asset value
per share
2



Total
Liabilities (CHF million)   
Due to banks 0 413 0 413
Customer deposits 0 3,895 448 4,343
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 0 13,688 0 13,688
Obligation to return securities received as collateral 44,074 6,598 101 50,773
Trading liabilities 33,543 138,018 4,246 (129,937) 1 45,871
   of which equity securities  20,527 111 55 1 20,694
   of which derivatives  10,535 132,956 4,191 (129,937) 17,745
      of which interest rate products  3,264 68,229 169
      of which foreign exchange products  51 28,819 72
      of which equity/index-related products  7,149 30,612 2,010
      of which credit derivatives  0 4,663 1,335
Short-term borrowings 0 10,039 701 10,740
Long-term debt 0 62,957 7,286 70,243
   of which structured notes over one year and up to two years  0 11,787 1,133 12,920
   of which structured notes over two years  0 28,330 5,526 33,856
   of which high-trigger instruments  0 10,627 0 10,627
Other liabilities 0 6,675 1,250 (169) 7,756
Total liabilities at fair value  77,617 242,283 14,032 (130,106) 1 203,827
1
Derivative contracts are reported on a gross basis by level. The impact of netting represents legally enforceable master netting agreements.
2
In accordance with US GAAP, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet.
Assets and liabilities measured at fair value on a recurring basis for level 3
   
Trading revenues

Other revenues
Accumulated other
comprehensive income

6M21

Balance at
beginning
of period


Transfers
in


Transfers
out



Purchases



Sales



Issuances



Settlements

On
transfers
out


On all
other

On
transfers
out


On all
other

On
transfers
out


On all
other
Foreign
currency
translation
impact

Balance
at end
of period

Changes in
unrealized
gains/losses
1
Assets (CHF million)   
Securities received as collateral 101 0 0 64 (86) 0 0 0 0 0 0 0 0 5 84 0
Trading assets 7,535 594 (1,635) 2,472 (2,976) 508 (1,119) 39 140 0 0 0 0 380 5,938 128
   of which debt securities  2,253 296 (736) 1,859 (2,285) 0 0 (7) 138 0 0 0 0 137 1,655 103
      of which corporates  1,270 137 (176) 1,403 (1,913) 0 0 (5) 95 0 0 0 0 78 889 99
   of which derivatives  3,911 179 (856) 0 0 508 (1,033) 29 (30) 0 0 0 0 175 2,883 72
      of which interest rate products  733 59 (81) 0 0 114 (59) 0 18 0 0 0 0 21 805 54
      of which other derivatives  1,079 0 0 0 0 153 (157) 0 (55) 0 0 0 0 53 1,073 (60)
   of which other trading assets  1,247 22 (32) 493 (617) 0 (86) 10 21 0 0 0 0 60 1,118 (47)
Other investments 3,054 3 (753) 20 (473) 0 0 0 (17) 0 318 0 0 79 2,231 46
   of which other equity investments  2,132 0 (753) 3 (375) 0 0 0 (6) 0 318 0 0 34 1,353 55
   of which life finance instruments  920 0 0 17 (94) 0 0 0 (11) 0 0 0 0 45 877 18
Loans 2 3,669 22 (533) 357 (73) 162 (946) 8 85 0 1 0 0 176 2,928 25
   of which commercial and industrial loans 2 1,347 22 (12) 10 (31) 119 (184) 14 57 0 1 0 0 68 1,411 36
   of which financial institutions  1,082 0 (222) 0 (42) 32 (296) 3 40 0 0 0 0 46 643 4
Other intangible assets (mortgage servicing rights) 180 0 0 22 0 0 0 0 0 0 (22) 0 0 9 189 (22)
Other assets 1,825 164 (451) 2,500 (2,176) 77 (573) 13 (42) 0 0 0 0 99 1,436 (76)
   of which loans held-for-sale  1,576 164 (409) 2,469 (2,137) 77 (571) 11 19 0 0 0 0 88 1,287 (41)
Total assets at fair value  16,364 783 (3,372) 5,435 (5,784) 747 (2,638) 60 166 0 297 0 0 748 12,806 101
Liabilities (CHF million)   
Customer deposits 448 0 0 0 0 0 0 0 (8) 0 0 0 (13) 5 432 10
Obligation to return securities received as collateral 101 0 0 64 (86) 0 0 0 0 0 0 0 0 5 84 0
Trading liabilities 4,246 584 (1,961) 80 (24) 710 (1,138) 152 169 0 0 0 0 217 3,035 779
   of which derivatives  4,191 566 (1,961) 69 (4) 710 (1,138) 152 193 0 0 0 0 216 2,994 781
      of which equity/index-related derivatives  2,010 427 (1,049) 0 0 350 (527) 151 265 0 0 0 0 111 1,738 529
Short-term borrowings 701 155 (207) 0 0 930 (608) (1) 95 0 0 0 0 41 1,106 67
Long-term debt 7,286 2,697 (2,046) 0 0 4,401 (3,119) 62 (8) 0 0 (3) (30) 433 9,673 203
   of which structured notes over one year and up to two years  1,133 1,165 (732) 0 0 1,127 (771) 39 97 0 0 0 (1) 67 2,124 39
   of which structured notes over two years  5,526 1,532 (1,287) 0 0 3,020 (2,227) 24 (109) 0 0 (2) (29) 329 6,777 (59)
Other liabilities 1,250 7 (533) 24 (46) 59 (416) 8 (8) 102 38 0 0 50 535 2
Total liabilities at fair value  14,032 3,443 (4,747) 168 (156) 6,100 (5,281) 221 240 102 38 (3) (43) 751 14,865 1,061
Net assets/(liabilities) at fair value  2,332 (2,660) 1,375 5,267 (5,628) (5,353) 2,643 (161) (74) (102) 259 3 43 (3) (2,059) (960)
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in unrealized (gains)/losses on total liabilities at fair value relating to assets and liabilities held at period end are included in net revenues or accumulated other comprehensive income. As of 6M21, changes in net unrealized gains/(losses) of CHF (1,003) million and CHF 28 million were recorded in trading revenues and other revenues, respectively, and changes in unrealized (gains)/losses of CHF 15 million were recorded in Gains/(losses) on liabilities relating to credit risk in Accumulated other comprehensive income/(loss).
 
Assets and liabilities measured at fair value on a recurring basis for level 3 (continued)
   
Trading revenues

Other revenues
Accumulated other
comprehensive income

6M20

Balance at
beginning
of period


Transfers
in


Transfers
out



Purchases



Sales



Issuances



Settlements

On
transfers
out


On all
other

On
transfers
out


On all
other

On
transfers
out


On all
other
Foreign
currency
translation
impact

Balance
at end
of period

Changes in
unrealized
gains/losses
1
Assets (CHF million)   
Securities received as collateral 1 0 0 173 (1) 0 0 0 0 0 0 0 0 (3) 170 0
Trading assets 7,885 2,489 (1,502) 4,272 (4,657) 1,290 (1,625) 169 796 (1) 0 0 0 (319) 8,797 1,076
   of which debt securities  1,923 1,654 (708) 2,527 (2,000) 0 0 59 (122) 0 0 0 0 (135) 3,198 (19)
      of which corporates  1,128 559 (564) 1,718 (1,230) 0 0 67 42 0 0 0 0 (78) 1,642 96
      of which RMBS  317 902 (70) 557 (525) 0 0 (4) (70) 0 0 0 0 (5) 1,102 (55)
   of which derivatives  3,534 719 (629) 0 0 1,290 (1,606) 111 834 (1) 0 0 0 (151) 4,101 999
      of which equity/index-related products  1,040 220 (240) 0 0 345 (597) 35 345 0 0 0 0 (81) 1,067 361
      of which credit derivatives  879 379 (305) 0 0 700 (771) 100 211 0 0 0 0 (21) 1,172 325
      of which other derivatives  909 0 0 0 0 155 (165) 0 207 0 0 0 0 (21) 1,085 210
   of which other trading assets  2,231 100 (144) 1,707 (2,639) 0 (19) (1) 151 0 0 0 0 (30) 1,356 11
Other investments 2,523 2 0 371 (107) 0 0 0 95 0 (19) 0 0 (26) 2,839 38
   of which other equity investments  1,463 1 0 354 (19) 0 0 0 (11) 0 (18) 0 0 (5) 1,765 (35)
   of which life finance instruments  1,052 0 0 17 (88) 0 0 0 106 0 0 0 0 (21) 1,066 74
Loans 2 3,835 641 (375) 90 (479) 742 (569) 38 (336) 0 0 0 0 (74) 3,513 (296)
   of which commercial and industrial loans 2 1,402 390 (137) 45 (282) 447 (173) 3 (194) 0 0 0 0 (28) 1,473 (205)
   of which financial institutions  1,201 44 (94) 0 (32) 275 (211) 13 (70) 0 0 0 0 (26) 1,100 (77)
Other intangible assets (mortgage servicing rights) 244 0 0 0 0 0 0 0 0 0 (31) 0 0 (4) 209 (31)
Other assets 1,846 1,432 (383) 2,400 (2,260) 282 (543) 16 (60) 0 0 0 0 (149) 2,581 (6)
   of which loans held-for-sale  1,619 1,409 (339) 2,373 (2,259) 282 (543) (8) (87) 0 0 0 0 (143) 2,304 (87)
Total assets at fair value  16,334 4,564 (2,260) 7,306 (7,504) 2,314 (2,737) 223 495 (1) (50) 0 0 (575) 18,109 781
Liabilities (CHF million)   
Customer deposits 474 0 0 0 0 0 (27) 0 35 0 0 0 (22) (27) 433 9
Obligation to return securities received as collateral 1 0 0 173 (1) 0 0 0 0 0 0 0 0 (3) 170 0
Trading liabilities 3,854 513 (904) 210 (195) 1,602 (1,276) 184 (151) (5) 0 0 0 (105) 3,727 577
   of which derivatives  3,801 497 (904) 0 (3) 1,602 (1,276) 184 (136) (5) 0 0 0 (103) 3,657 575
      of which equity/index-related derivatives  1,921 126 (493) 0 0 585 (486) 69 (262) 0 0 0 0 (59) 1,401 274
      of which credit derivatives  1,211 333 (373) 0 0 896 (574) 117 (21) 0 0 0 0 (31) 1,558 135
Short-term borrowings 997 52 (200) 0 0 470 (706) (2) (118) 0 0 0 0 (13) 480 (40)
Long-term debt 12,749 1,720 (5,514) 0 0 4,294 (3,614) 461 (1,241) 0 0 87 (165) (272) 8,505 (107)
   of which structured notes over one year and up to two years  891 186 (423) 0 0 632 (435) 28 (111) 0 0 1 5 (18) 756 (30)
   of which structured notes over two years  11,458 707 (5,077) 0 0 3,631 (3,140) 433 (1,138) 0 0 87 (170) (245) 6,546 (89)
Other liabilities 1,367 168 (112) 195 (227) 64 (283) (27) (17) 0 84 0 0 (27) 1,185 44
Total liabilities at fair value  19,442 2,453 (6,730) 578 (423) 6,430 (5,906) 616 (1,492) (5) 84 87 (187) (447) 14,500 483
Net assets/(liabilities) at fair value  (3,108) 2,111 4,470 6,728 (7,081) (4,116) 3,169 (393) 1,987 4 (134) (87) 187 (128) 3,609 298
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in unrealized (gains)/losses on total liabilities at fair value relating to assets and liabilities held at period end are included in net revenues. As of 6M20, changes in net unrealized gains/(losses) of CHF 284 million and CHF (36) million were recorded in trading revenues and other revenues, respectively, and changes in unrealized (gains)/losses of CHF 50 million were recorded in Gains/(losses) on liabilities relating to credit risk in Accumulated other comprehensive income/(loss).
2
Includes an adjustment of CHF 119 million reflecting the impact of applying the fair value option on certain loans (previously held at amortized cost) at the adoption of the ASU 2019-05.
 
Difference between the fair value and the unpaid principal balances of fair value option-elected financial instruments
   6M21 2020

end of
Aggregate
fair
value
Aggregate
unpaid
principal


Difference
Aggregate
fair
value
Aggregate
unpaid
principal


Difference
Financial instruments (CHF million)   
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 69,465 69,314 151 57,994 57,895 99
Loans 11,101 11,804 (703) 11,408 12,079 (671)
Other assets 1 9,448 12,122 (2,674) 7,834 10,090 (2,256)
Due to banks and customer deposits (538) (471) (67) (578) (489) (89)
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions (11,080) (11,079) (1) (13,688) (13,672) (16)
Short-term borrowings (8,554) (8,556) 2 (10,740) (10,632) (108)
Long-term debt 2 (68,486) (70,327) 1,841 (70,243) (73,175) 2,932
Other liabilities (883) (1,844) 961 (616) (1,569) 953
Non-performing and non-interest-earning loans 3 591 3,543 (2,952) 543 3,364 (2,821)
1
Primarily loans held-for-sale.
2
Long-term debt includes both principal-protected and non-principal protected instruments. For non-principal-protected instruments, the original notional amount has been reported in the aggregate unpaid principal.
3
Included in loans or other assets.
Gains and losses on financial instruments
   6M21 6M20

in
Net
gains/
(losses)
Net
gains/
(losses)
Financial instruments (CHF million)   
Interest-bearing deposits with banks 18 1 1 1
   of which related to credit risk  8 (6)
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 306 1 789 1
Other investments 293 2 205 3
   of which related to credit risk  0 1
Loans 277 1 (247) 3
   of which related to credit risk  59 (575)
Other assets 405 1 416 1
   of which related to credit risk  173 (19)
Due to banks and customer deposits (37) 3 (39) 3
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions (29) 1 (82) 1
Short-term borrowings (406) 3 (16) 3
   of which related to credit risk  (1) 1
Long-term debt (3,347) 3 1,842 3
   of which related to credit risk  0 14
Other liabilities 120 2 (102) 3
   of which related to credit risk  67 (124)
1
Primarily recognized in net interest income.
2
Primarily recognized in other revenues.
3
Primarily recognized in trading revenues.
Gains/(losses) attributable to changes in investment-specific credit risk
    

Gains/(losses) recorded into AOCI
1 Gains/(losses) recorded
in AOCI transferred
to net income
1
in 6M21 Cumulative 6M20 6M21 6M20
Financial instruments (CHF million)   
Customer deposits 13 (64) 23 0 0
Short-term borrowings 13 (55) (22) 0 0
Long-term debt (21) (2,397) 1,723 77 99
   of which treasury debt over two years  (321) (1,044) 1,306 0 0
   of which structured notes over two years  269 (1,262) 300 77 99
Total  5 (2,516) 1,724 77 99
1
Amounts are reflected gross of tax.
Carrying value and fair value of financial instruments not carried at fair value
    Carrying
value

Fair value
end of Level 1 Level 2 Level 3 Total
6M21 (CHF million)
Financial assets 
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 25,179 0 25,180 0 25,180
Loans 293,508 0 288,871 13,252 302,123
Other financial assets 1 160,724 144,457 16,058 273 160,788
Financial liabilities 
Due to banks and customer deposits 415,020 239,969 175,118 0 415,087
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 9,941 0 9,941 0 9,941
Short-term borrowings 17,665 0 17,666 0 17,666
Long-term debt 95,807 0 95,840 2,955 98,795
Other financial liabilities 2 14,484 0 14,069 382 14,451
2020 (CHF million)
Financial assets 
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions 21,139 0 21,139 0 21,139
Loans 285,570 0 281,097 14,534 295,631
Other financial assets 1 154,441 137,763 16,399 302 154,464
Financial liabilities 
Due to banks and customer deposits 403,704 235,477 168,262 0 403,739
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions 10,256 0 10,256 0 10,256
Short-term borrowings 10,568 0 10,569 0 10,569
Long-term debt 90,035 0 90,716 2,317 93,033
Other financial liabilities 2 16,131 0 15,694 403 16,097
1
Primarily includes cash and due from banks, interest-bearing deposits with banks, loans held-for-sale, cash collateral on derivative instruments, interest and fee receivables and non-marketable equity securities.
2
Primarily includes cash collateral on derivative instruments and interest and fee payables.